Speaker:

Mellar Davis, MD, Palliative Medicine, Geisinger - has nothing to disclose.

Moderator:

Dan Hoegen, LSW,HEC-C, Clinical Ethicist, Geisinger - has nothing to disclose.

Learning Objectives:

At the conclusion of this session, the participant should be able to:
1) Explain the ethical complexity of providing opioid analgesics to patients with an active substance use disorder.
2) Discuss the management of opioids in patients with a substance disorder is based on a relationship (connection) and mutual respect and obligation of both parties.
3) Describe the differences in managing addiction and cancer pain by deontology, harms reduction or recovery.
 

Disclosure of Relevant Financial Relationships with/without Commercial Interests:


The Planning Committee consisting of Daniel Hoegen, LSW, HEC-C; Michelle Meyer, PhD, JD; F. Daniel Davis, PhD, HEC-C; Sharon Gray, MA, BSN, RN, HEC-C; Christopher Chabris, PhD; Greg Burke, MD; John Pagnotto, MD; Elizabeth McDonald, RD; Linda Page, RT; Ronald Napikoski, RT; Dean Parry, RPh; Kaylee Kachurka, PA-C; Erin Hall, PsyD and Anne Kasper have no identified disclosures.


CE Committee Member/Content Reviewers have nothing to disclose.


Any/All relevant financial relationships have been mitigated.

Content Disclosure:

This presentation/content is HIPPA compliant.

Commercial Support for this Session

None 

 

Session date: 
05/01/2024 - 4:00pm to 5:00pm EDT
Location: 
Weiss Conference Room
Danville, PA
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category I CME
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Approved for APA Credit
  • 1.00 ASWB
  • 1.00 CDR
  • 1.00 Participation Credit

Please login or register to take this course.